186 filings
Page 8 of 10
6-K
b2b jqwzgfnghc5
16 Mar 18
Current report (foreign)
12:00am
D
tiw krq8286mp2cnu2
28 Feb 18
$55.8M in equity, sold $55.8M, 9 investors
12:00am
6-K
pp2oo
16 Feb 18
Current report (foreign)
12:00am
6-K
3f53t37zitkh ma6
1 Dec 17
Unaudited Condensed Consolidated Statement of Financial Position
12:00am
6-K
s6afio86l eii52v
22 Sep 17
Unaudited Condensed Consolidated Statement of Financial Position
12:00am
6-K
nqc3i5plkzk6woh8bv2
11 Jul 17
Unaudited Condensed Consolidated Statement of Financial Position
12:00am
EFFECT
zb74by jcsgviwnnezz
16 Jun 17
Notice of effectiveness
12:00am
CORRESP
m9a5f8ggmllu 8qj
14 Jun 17
Correspondence with SEC
12:00am
F-3/A
t7k wtzst
14 Jun 17
Shelf registration (foreign) (amended)
12:00am
UPLOAD
5j26epfhsd7pb5fj2jqv
9 Jun 17
Letter from SEC
12:00am
6-K
dwoml0nq 6a3n49
6 Jun 17
Current report (foreign)
12:00am
CT ORDER
4n3h7k516bkafna
6 Jun 17
Confidential treatment order
12:00am
F-3
481 wg5qzj
1 Jun 17
Shelf registration (foreign)
12:00am
6-K
lykp2mwbji z0phvz
1 Jun 17
Minutes of the Annual General Meeting of Shareholders
12:00am
6-K/A
l2efg5
10 May 17
Correcting and Replacing – Merus Announces Fourth Quarter and Full Year 2016 Financial Results and Corporate Developments
12:00am
6-K
lgyeau9ihbwi
9 May 17
Current report (foreign)
12:00am
20-F
a3oyuz6s19x
28 Apr 17
Annual report (foreign)
12:00am
6-K
ko6f3o01x2z2
28 Apr 17
Merus Announces Fourth Quarter and Full Year 2016 Financial Results and Corporate Developments
12:00am
6-K
khnpzip
25 Jan 17
Merus Announces Closing of Global Strategic Research Collaboration with Incyte to Discover and Develop Bispecific Antibodies
12:00am
D
umm06d
24 Jan 17
$80M in equity, sold $80M, 1 investor
12:00am